Lifecare is pleased to announce that it has raised approx. NOK 26 million in gross proceeds through the Private Placement of 15,467,834 new shares in the Company (the “Offer Shares”), at a price per Offer Share of NOK 1.70 (the “Offer Price”). The Private Placement took place through an accelerated bookbuilding process between 4 October 2021 09:00 CEST and 5 October 2021 16:30 CEST with Carnegie AS as bookrunner and manager (the “Manager”).
Lifecare intends to use the net proceeds from the Private Placement for: (i) further research, development and clinical studies of the implantable sensor Sencell towards CE mark, (ii) strengthening the Company’s balance sheet to ensure financial capacity and flexibility to pursue growth opportunities, (iii) working capital as well as for general corporate purposes, and (iv) continue to develop the organization and internationalize the Company.
Completion of Private Placement